Beacon Pointe Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.72M | Sell |
20,694
-2,000
| -9% | -$166K | 0.02% | 511 |
|
|
2025
Q1 | $1.84M | Sell |
22,694
-50
| -0.2% | -$4.06K | 0.02% | 479 |
|
|
2024
Q4 | $2.05M | Sell |
22,744
-1,990
| -8% | -$179K | 0.02% | 454 |
|
|
2024
Q3 | $2.44M | Buy |
24,734
+2,058
| +9% | +$203K | 0.03% | 428 |
|
|
2024
Q2 | $2.1M | Buy |
22,676
+845
| +4% | +$78.3K | 0.02% | 461 |
|
|
2024
Q1 | $2.07M | Sell |
21,831
-32,115
| -60% | -$3.05M | 0.02% | 489 |
|
|
2023
Q4 | $4.82M | Buy |
53,946
+27,623
| +105% | +$2.47M | 0.06% | 293 |
|
|
2023
Q3 | $1.92M | Buy |
26,323
+2,920
| +12% | +$213K | 0.02% | 465 |
|
|
2023
Q2 | $1.95M | Buy |
23,403
+509
| +2% | +$42.3K | 0.03% | 380 |
|
|
2023
Q1 | $1.74M | Buy |
22,894
+850
| +4% | +$64.8K | 0.03% | 424 |
|
|
2022
Q4 | $1.83M | Buy |
22,044
+4,277
| +24% | +$355K | 0.04% | 375 |
|
|
2022
Q3 | $1.42M | Buy |
17,767
+402
| +2% | +$32K | 0.03% | 394 |
|
|
2022
Q2 | $1.29M | Sell |
17,365
-1,333
| -7% | -$98.6K | 0.03% | 411 |
|
|
2022
Q1 | $1.68M | Buy |
18,698
+3,561
| +24% | +$320K | 0.02% | 485 |
|
|
2021
Q4 | $1.7M | Sell |
15,137
-1,206
| -7% | -$135K | 0.04% | 276 |
|
|
2021
Q3 | $2.05M | Buy |
16,343
+11,082
| +211% | +$1.39M | 0.05% | 280 |
|
|
2021
Q2 | $712K | Buy |
+5,261
| New | +$712K | 0.03% | 397 |
|